Skip to main content
. 2021 Jun 21;11:12984. doi: 10.1038/s41598-021-92503-6

Table 2.

Comparison of surgical findings in patient groups with and without extrahepatic recurrence.

Patients without extrahepatic recurrence (n = 304) Patients with extrahepatic recurrence (n = 94) p-value
Margin involvement, n (%) 9 (3.0) 6 (6.5) 0.134
Microvascular invasion, n (%) 51 (16.9) 28 (29.8) 0.006
Serosal invasion, n (%) 6 (2.1) 6 (6.5) 0.034
Bile duct invasion, n (%) 1 (0.3) 2 (2.25) 0.085
Capsule formation, n (%) 211 (73.3) 64 (68.8) 0.405
Multicentricity, n (%) 34 (11.7) 9 (9.7) 0.593
Satellite nodule, n (%) 38 (13.0) 29 (31.2)  < 0.001
Underlying liver cirrhosis, n (%) 201 (66.1) 61 (64.9) 0.827
Intrahepatic metastasis, n (%) 3 (1.0) 2 (2.1) 0.830
Necrosis, n (%) 136 (46.9) 64 (68.8)  < 0.001
Haemorrhage, n (%) 139 (47.9) 53 (57.0) 0.121
Fatty change, n (%) 109 (38.0) 29 (31.9) 0.291
Cell type, n (%) 0.213

Clear type

Hepatic type

Classic type

53 (17.5)

271 (89.4)

240 (79.2)

22 (23.4)

89 (94.6)

70 (74.5)

Major Edmondson Steiner grade, n (%) 0.336

1/2

3/4

14 (4.8)/152 (52.2)

116 (39.9)/9 (3.1)

4 (4.3)/39 (41.9)

46 (49.5)/4 (4.3)

Worst Edmondson Steiner grade, n (%) 0.665

1/2

3/4

2 (0.7)/46 (15.8)

178 (61.2)/65 (22.3)

2 (2.2)/14 (15.1)

55 (59.1)/22 (23.7)